두개내압(ICP) 모니터링 기기 시장 규모 : 제품별, 기술별, 용도별, 최종 용도별 예측(2024-2032년)

Global Intracranial Pressure (ICP) Monitoring Devices Market size will record a 6.8% CAGR from 2024 to 2032, propelled by advancements in healthcare infrastructure and the increasing demand for non-invasive monitoring methods. Improved healthcare facilities, especially in developing regions, are enhancing access to neurosurgical procedures, including ICP monitoring. Furthermore, the preference for non-invasive or minimally invasive monitoring solutions is growing among patients and healthcare providers. These trends signify a shift towards more effective, patient-friendly monitoring options, driving innovation in ICP devices and expanding their market size.

The intracranial pressure (ICP) monitoring devices industry is segmented based on offering, technology, application, end-use, and region.

The clinics segment will encounter a marked upturn by 2032 due to the increasing trend toward outpatient care, where clinics offer convenient access to monitoring services. Advancements in technology have led to the development of compact and user-friendly monitoring solutions that align well with the clinic environment. With a rising number of specialized neurology clinics and a focus on efficient brain health services, clinics are becoming pivotal in managing neurological conditions, contributing significantly to the broader market outlook.

The intracranial pressure (ICP) monitoring devices market share from intracerebral hemorrhage segment will witness a considerable upsurge by 2032, fueled by the critical need for continuous monitoring in patients with this condition, as it helps in early detection and intervention. As intracerebral hemorrhage poses significant risks of increased intracranial pressure, the demand for monitoring devices is high to prevent secondary brain injury. Advancements in technology, such as non-invasive monitoring options, further drive the growth of this segment within the ICP monitoring devices market.

Asia Pacific intracranial pressure (ICP) monitoring devices industry share will exhibit a remarkable CAGR from 2024 to 2032, attributed to burgeoning healthcare infrastructure, a rising geriatric population, and expanding access to advanced medical technologies. The region's increasing incidence of traumatic brain injuries and neurological disorders also contributes to this trend. With a proactive approach to healthcare modernization and substantial investments in research and development, Asia Pacific will stand as a key contributor to the growth of the intracranial pressure (ICP) monitoring devices market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast calculations
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of various neurological disorders and traumatic accidents
    • 3.2.1.2 Advancements in new technologies
    • 3.2.1.3 Growing government initiatives and policies
    • 3.2.1.4 Rising awareness and screening programs
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated with these monitoring devices
    • 3.2.2.2 Related complications and adverse effects
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Offering, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Products & systems
• 5.3 Solutions & platforms

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Invasive
  • 6.2.1 External ventricular drainage (EVD)
  • 6.2.2 Microtransducer ICP monitoring
• 6.3 Non-invasive
  • 6.3.1 Transcranial doppler ultrasonography
  • 6.3.2 Tympanic membrane displacement (TMD)
  • 6.3.3 Optic nerve sheath diameter
  • 6.3.4 MRI/CT
  • 6.3.5 Electroencephalography
  • 6.3.6 Fundoscopy (Papilledema)

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Traumatic brain injury
• 7.3 Intracerebral hemorrhage
• 7.4 Meningitis
• 7.5 Subarachnoid hemorrhage
• 7.6 CSF management
• 7.7 Migraine
• 7.8 Stroke
• 7.9 Hydrocephalus
• 7.10 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Clinics
• 8.4 Diagnostic laboratories
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Brain4Care Inc.
• 10.2 CranioSense, LLC.
• 10.3 HeadSense Medical Ltd
• 10.4 Integra LifeScience Holdings Corporation
• 10.5 Johnson & Johnson
• 10.6 Luciole Medical AG
• 10.7 Medtronic plc
• 10.8 Natus Medical Incorporated
• 10.9 RAUMEDIC AG
• 10.10 Sophysa
• 10.11 Vittamed Corporation